Literature DB >> 31956207

Superior Vena Cava Lymphoma.

Fumiya Ogasawara1, Yu Nakatani2, Kensuke Kojima1.   

Abstract

Entities:  

Keywords:  diffuse large B cell lymphoma; superior vena cava syndrome; thrombosis

Year:  2020        PMID: 31956207      PMCID: PMC7270768          DOI: 10.2169/internalmedicine.4140-19

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 71-year-old woman presented to the emergency department with a 2-month history of shortness of breath, non-productive cough, and facial swelling. Lymphoma-associated B symptoms (fever, night sweats, and weight loss) were absent. Computed tomography showed a mass in the superior vena cava (SVC) along with right internal jugular vein thrombosis and bilateral non-malignant pleural effusions (Picture). The vascular lumen of the superior vena cava appeared to be intact. 18F-Fluorodeoxyglucose (FDG) positron emission tomography showed an intense uptake in the SVC tumor. A biopsy specimen of the subcarinal lymph node revealed histologic features of diffuse large B cell lymphoma (DLBCL) with the GCB immunophenotype (CD20+CD10+BCL6+MUM1-CD30-). She received R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) along with warfarin, leading to the disappearance of the lymphoma lesions, pleural effusion, and internal jugular vein thrombosis. Our experience suggests the importance of an early lymphoma diagnosis with potentially life-threatening SVC syndrome (1,2).
Picture.
Written informed consent was obtained from the patient for publication.

The authors state that they have no Conflict of Interest (COI). Fumiya Ogasawara and Yu Nakatani contributed equally to this work.
  2 in total

1.  Primary malignant lymphoma of superior vena cava.

Authors:  H Nomori; S Nara; S Morinaga; K Soejima
Journal:  Ann Thorac Surg       Date:  1998-10       Impact factor: 4.330

2.  Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava.

Authors:  Shingen Nakamura; Kumiko Kagawa; Ryohei Sumitani; Munenori Uemura; Mamiko Takahashi; Masami Iwasa; Shiro Fujii; Hirokazu Miki; Masahiro Abe
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.